Aimei Health Technology (NASDAQ:AFJK) Receives "Sell (D+)" Rating from Weiss Ratings

Key Points

• Aimei Health Technology (NASDAQ:AFJK) has received a "Sell (D+)" rating from Weiss Ratings, indicating a negative outlook for the company's stock.
• The company's stock currently trades at $11.32, having a market capitalization of approximately $69.28 million and a PE ratio of 49.22.
• Several institutional investors recently increased their stakes in Aimei Health Technology, now owning 45.58% of the company's stock, demonstrating growing interest from larger investors.

Aimei Health Technology (NASDAQ:AFJK - Get Free Report)'s stock had its "sell (d+)" rating reissued by research analysts at Weiss Ratings in a research note issued to investors on Wednesday,Weiss Ratings reports.

Aimei Health Technology Trading Down 0.2%

NASDAQ:AFJK traded down $0.02 during midday trading on Wednesday, hitting $11.32. 4 shares of the company were exchanged, compared to its average volume of 2,345. The company has a fifty day simple moving average of $11.26 and a 200 day simple moving average of $11.15. The company has a market capitalization of $69.28 million, a PE ratio of 49.22 and a beta of -0.03. Aimei Health Technology has a fifty-two week low of $10.24 and a fifty-two week high of $11.34.

Aimei Health Technology (NASDAQ:AFJK - Get Free Report) last released its quarterly earnings results on Wednesday, August 13th. The company reported $0.07 EPS for the quarter.

Hedge Funds Weigh In On Aimei Health Technology

Several institutional investors and hedge funds have recently modified their holdings of AFJK. Polar Asset Management Partners Inc. purchased a new position in shares of Aimei Health Technology during the first quarter valued at approximately $110,000. Wellspring Financial Advisors LLC purchased a new position in shares of Aimei Health Technology during the second quarter valued at approximately $133,000. Clear Street LLC lifted its stake in shares of Aimei Health Technology by 63.8% during the second quarter. Clear Street LLC now owns 39,525 shares of the company's stock valued at $441,000 after buying an additional 15,399 shares during the period. Quarry LP lifted its stake in shares of Aimei Health Technology by 4.7% during the first quarter. Quarry LP now owns 157,081 shares of the company's stock valued at $1,729,000 after buying an additional 7,081 shares during the period. Finally, Crossingbridge Advisors LLC purchased a new position in shares of Aimei Health Technology during the second quarter valued at approximately $2,147,000. Hedge funds and other institutional investors own 45.58% of the company's stock.

Aimei Health Technology Company Profile

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.